SFI
BLFS icon

Susquehanna Fundamental Investments’s BioLife Solutions BLFS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,600
Closed -$294K – 1702
2021
Q2 		$294K Sell
6,600
-3,165
-32% -$112K 0.01% 1376
2021
Q1 		$352K Buy
9,765
+820
+9% +$32.4K 0.01% 1254
2020
Q4 		$357K Buy
+8,945
New +$305K 0.01% 1212

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Susquehanna Fundamental Investments's BLFS Position: Q3 2021 in Review

Susquehanna Fundamental Investments sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 6,600 shares — an estimated $294K sold.

Susquehanna Fundamental Investments first reported a position in BLFS in Q4 2020 and held it in 3 quarters. The position peaked at $357K in Q4 2020. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

  • Susquehanna Fundamental Investments reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 6,600 BioLife Solutions shares in Q3 2021, an estimated $294K.
  • Susquehanna Fundamental Investments first reported a position in BioLife Solutions in Q4 2020 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's BioLife Solutions position peaked at $357K in Q4 2020.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2021, filed 15 Nov 2021.